TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Efficacy of the Proximate Administration of Oxytocin After a Traumatic Event in Preventing the Development of Post Traumatic Stress Disorder
Brief Summary: This study is designed to test the hypothesis that a single administration of intranasal oxytocin within 6 hours post-trauma facilitates the physiological recovery for the trauma, thereby preventing the development of Post Traumatic Stress Disorder (PTSD) in the months following the event. In the absence of such treatment (i.e., under placebo conditions), we hypothesize that a greater proportion of persons will develop PTSD (i.e., fail to recover from acute effects).


Options:
A: Arm Label: oxytocin; Type: EXPERIMENTAL; Interventions: Drug: Oxytocin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo - saline nasal spray | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): oxytocin | Intervention Type: DRUG; Name: placebo - saline nasal spray; Assigned to Arm(s): Placebo
B: Arm Label: Arm 1: Hydrocortisone; Type: EXPERIMENTAL; Interventions: Drug: Hydrocortisone | Arm Label: Arm 2: D-Cycloserine; Type: EXPERIMENTAL; Interventions: Drug: D-Cycloserine | Arm Label: Arm 3: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Hydrocortisone; Assigned to Arm(s): Arm 1: Hydrocortisone | Intervention Type: DRUG; Name: D-Cycloserine; Assigned to Arm(s): Arm 2: D-Cycloserine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 3: Placebo
C: Arm Label: Ketamine arm; Type: EXPERIMENTAL; Interventions: Drug: Ketamine | Arm Label: Placebo arm; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ketamine; Assigned to Arm(s): Ketamine arm | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo arm
D: Arm Label: saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Hydrocortisone; Type: EXPERIMENTAL; Interventions: Drug: Hydrocortisone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): saline | Intervention Type: DRUG; Name: Hydrocortisone; Assigned to Arm(s): Hydrocortisone

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Sensori-motor Integration Balance Training on Balance Disturbances in Patients With Multiple Sclerosis
Brief Summary: Balance impairment is a common and very disabling disturbance in people with Multiple Sclerosis. The efficacy of pharmacotherapy in treating balance impairment in MS is poorly documented in literature. Although literature dealing with the rehabilitation of balance impairment in MS is very scant, the preliminary data reports show very promising results. The present project could have a positive impact on balance and gait ability, disability, fear of falling, risk of falls and quality of life of patients with Multiple Sclerosis.


Options:
A: Arm Label: Free From Falls; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Free From Falls Online | Arm Label: Waitlist; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Waitlist Control | Intervention Type: BEHAVIORAL; Name: Free From Falls Online; Assigned to Arm(s): Free From Falls | Intervention Type: BEHAVIORAL; Name: Waitlist Control; Assigned to Arm(s): Waitlist
B: Arm Label: Group balance training early start; Type: EXPERIMENTAL; Interventions: Other: Group balance training | Arm Label: Group balance training late start; Type: EXPERIMENTAL; Interventions: Other: Group balance training | Intervention Type: OTHER; Name: Group balance training; Assigned to Arm(s): Group balance training early start, Group balance training late start
C: Arm Label: Sensory-motor Integration Training; Type: EXPERIMENTAL; Interventions: Procedure: Sensory-motor Integration Training | Arm Label: Conventional neurorehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional neurorehabilitation treatment | Intervention Type: PROCEDURE; Name: Sensory-motor Integration Training; Assigned to Arm(s): Sensory-motor Integration Training | Intervention Type: PROCEDURE; Name: Conventional neurorehabilitation treatment; Assigned to Arm(s): Conventional neurorehabilitation
D: Arm Label: Home-based Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based exercise | Arm Label: Education; Type: EXPERIMENTAL; Interventions: Behavioral: Education | Arm Label: Exercise plus education; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise plus Education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home-based exercise; Assigned to Arm(s): Home-based Exercise | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education | Intervention Type: BEHAVIORAL; Name: Exercise plus Education; Assigned to Arm(s): Exercise plus education

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trichuris Suis Ova in Autism Spectrum Disorders
Brief Summary: The purpose of this study is to determine whether Trichuris Suis Ova (TSO) is safe and effective in treating adults with autism spectrum disorder


Options:
A: Arm Label: Atomoxetine; Type: EXPERIMENTAL; Interventions: Drug: Atomoxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Atomoxetine; Assigned to Arm(s): Atomoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Balovaptan; Type: EXPERIMENTAL; Interventions: Drug: Balovaptan | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Balovaptan; Assigned to Arm(s): Balovaptan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vasopressin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vasopressin | Intervention Type: DRUG; Name: Vasopressin; Assigned to Arm(s): Vasopressin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Trichuris Suis Ova (TSO); Type: EXPERIMENTAL; Interventions: Drug: Trichuris Suis Ova | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Trichuris Suis Ova | Intervention Type: DRUG; Name: Trichuris Suis Ova; Assigned to Arm(s): Placebo, Trichuris Suis Ova (TSO)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trichuris Suis Ova in Autism Spectrum Disorders
Brief Summary: The purpose of this study is to determine whether Trichuris Suis Ova (TSO) is safe and effective in treating adults with autism spectrum disorder


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: RG7314; Type: EXPERIMENTAL; Interventions: Drug: RG7314 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: RG7314; Assigned to Arm(s): RG7314
B: Arm Label: Trichuris Suis Ova (TSO); Type: EXPERIMENTAL; Interventions: Drug: Trichuris Suis Ova | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Trichuris Suis Ova | Intervention Type: DRUG; Name: Trichuris Suis Ova; Assigned to Arm(s): Placebo, Trichuris Suis Ova (TSO)
C: Arm Label: Intranasal Oxytocin; Type: EXPERIMENTAL; Interventions: Drug: Oxytocin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Intranasal Oxytocin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: olanzapine (Zyprexa) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: olanzapine (Zyprexa); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trichuris Suis Ova in Autism Spectrum Disorders
Brief Summary: The purpose of this study is to determine whether Trichuris Suis Ova (TSO) is safe and effective in treating adults with autism spectrum disorder


Options:
A: Arm Label: MPH Trial-Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: MPH Trial: Low Dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylphenidate-extended release, Drug: Methylphenidate-immediate release | Arm Label: MPH Trial: Med Dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylphenidate-extended release, Drug: Methylphenidate-immediate release | Arm Label: MPH Trial: High Dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylphenidate-extended release, Drug: Methylphenidate-immediate release | Intervention Type: DRUG; Name: Methylphenidate-extended release; Assigned to Arm(s): MPH Trial: High Dose, MPH Trial: Low Dose, MPH Trial: Med Dose | Intervention Type: DRUG; Name: Methylphenidate-immediate release; Assigned to Arm(s): MPH Trial: High Dose, MPH Trial: Low Dose, MPH Trial: Med Dose | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): MPH Trial-Placebo
B: Arm Label: Trichuris Suis Ova (TSO); Type: EXPERIMENTAL; Interventions: Drug: Trichuris Suis Ova | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Trichuris Suis Ova | Intervention Type: DRUG; Name: Trichuris Suis Ova; Assigned to Arm(s): Placebo, Trichuris Suis Ova (TSO)
C: Arm Label: Social Skills Focused CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Social Skills focused CBT | Arm Label: Stress Management/Relaxation Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stress management/relaxation training | Arm Label: Oxytocin; Type: EXPERIMENTAL; Interventions: Drug: Oxytocin | Arm Label: placebo drug; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo drug | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Oxytocin | Intervention Type: BEHAVIORAL; Name: Social Skills focused CBT; Assigned to Arm(s): Social Skills Focused CBT | Intervention Type: BEHAVIORAL; Name: Stress management/relaxation training; Assigned to Arm(s): Stress Management/Relaxation Training | Intervention Type: DRUG; Name: placebo drug; Assigned to Arm(s): placebo drug
D: Arm Label: Memantine; Type: EXPERIMENTAL; Interventions: Drug: Memantine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): Memantine | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized,Double-blind,Multicenter Phase III Trial to Evaluate the Safety and Efficacy of Icotinib and Gefitinib in Advanced NSCLC Patients Previously Treated With Chemotherapy
Brief Summary: The purpose of this study is to determine whether Icotinib is at least non-inferior to Gefitinib in the treatment of advanced non-small cell lung cancer (NSCLC) patients after one or two chemotherapies.


Options:
A: Arm Label: Pemetrexed/Cisplatin/Gefitinib; Type: EXPERIMENTAL; Interventions: Drug: Pemetrexed, Drug: Cisplatin, Drug: Gefitinib | Arm Label: Pemetrexed/Cisplatin; Type: EXPERIMENTAL; Interventions: Drug: Pemetrexed, Drug: Cisplatin | Intervention Type: DRUG; Name: Pemetrexed; Assigned to Arm(s): Pemetrexed/Cisplatin, Pemetrexed/Cisplatin/Gefitinib | Intervention Type: DRUG; Name: Cisplatin; Assigned to Arm(s): Pemetrexed/Cisplatin, Pemetrexed/Cisplatin/Gefitinib | Intervention Type: DRUG; Name: Gefitinib; Assigned to Arm(s): Pemetrexed/Cisplatin/Gefitinib
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Gefitinib | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carboplatin, Drug: Paclitaxel | Intervention Type: DRUG; Name: Gefitinib; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): 2
C: Arm Label: Icotinib; Type: EXPERIMENTAL; Interventions: Drug: Icotinib | Arm Label: Gefitinib; Type: ACTIVE_COMPARATOR; Interventions: Drug: Gefitinib | Intervention Type: DRUG; Name: Icotinib; Assigned to Arm(s): Icotinib | Intervention Type: DRUG; Name: Gefitinib; Assigned to Arm(s): Gefitinib
D: Arm Label: Paclitaxel/Carboplatin/Gefitinib; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel/Carboplatin/Gefitinib | Arm Label: Paclitaxel/Carboplatin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paclitaxel/Carboplatin | Intervention Type: DRUG; Name: Paclitaxel/Carboplatin/Gefitinib; Assigned to Arm(s): Paclitaxel/Carboplatin/Gefitinib | Intervention Type: DRUG; Name: Paclitaxel/Carboplatin; Assigned to Arm(s): Paclitaxel/Carboplatin

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Peer Coaching for Low-Income Patients With Diabetes in Primary Care
Brief Summary: Patients with diabetes who are counseled by a peer coach (another patient with diabetes) will have improved glycemic control compared with usual care patients.


Options:
A: Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse-led case management | Intervention Type: BEHAVIORAL; Name: Nurse-led case management; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): B
B: Arm Label: Group Clinic; Type: EXPERIMENTAL; Interventions: Behavioral: Improving outcomes using group clinics for older patients | Arm Label: Uusual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Standard of Care | Intervention Type: BEHAVIORAL; Name: Improving outcomes using group clinics for older patients; Assigned to Arm(s): Group Clinic | Intervention Type: BEHAVIORAL; Name: Standard of Care; Assigned to Arm(s): Uusual Care
C: Arm Label: Health coaching; Type: EXPERIMENTAL; Interventions: Behavioral: Health coaching | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care | Intervention Type: BEHAVIORAL; Name: Health coaching; Assigned to Arm(s): Health coaching
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Health coaching | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health coaching; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Addressing Health Literacy and Numeracy to Prevent Childhood Obesity
Brief Summary: In 2003, Surgeon General Richard Carmona suggested that low health literacy is "one of the largest contributors to our nation's epidemic of overweight and obesity." Over 26% of preschool children are now overweight or obese, and children who are overweight by age 24 months are five times as likely as non-overweight children to become overweight adolescents. The aim of the study is to assess the efficacy of a low-literacy/numeracy-oriented intervention aimed at teaching pediatric resident physicians to promote healthy family lifestyles and prevent overweight among young children (age 0-2) and their families in under-resourced communities.


Options:
A: Arm Label: parent intervention plus gym lessons; Type: EXPERIMENTAL; Interventions: Behavioral: parent-focused intervention, Behavioral: twice weekly gym lessons | Arm Label: gym lessons only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: twice weekly gym lessons | Intervention Type: BEHAVIORAL; Name: parent-focused intervention; Assigned to Arm(s): parent intervention plus gym lessons | Intervention Type: BEHAVIORAL; Name: twice weekly gym lessons; Assigned to Arm(s): gym lessons only, parent intervention plus gym lessons
B: Arm Label: Experimental: Phase 1 Usual Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Exposure | Arm Label: Experimental: Phase 1 Mealtime support activities; Type: EXPERIMENTAL; Interventions: Behavioral: Mealtime Supports | Arm Label: Experimental: Phase 2- Usual Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Exposure | Arm Label: Experimental: Phase 2- Meal Delivery and Receipt of Cookware; Type: EXPERIMENTAL; Interventions: Behavioral: Mealtime Supports | Intervention Type: BEHAVIORAL; Name: Mealtime Supports; Assigned to Arm(s): Experimental: Phase 1 Mealtime support activities, Experimental: Phase 2- Meal Delivery and Receipt of Cookware | Intervention Type: BEHAVIORAL; Name: Usual Exposure; Assigned to Arm(s): Experimental: Phase 1 Usual Exposure, Experimental: Phase 2- Usual Exposure
C: Arm Label: Active Control Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Injury Prevention Arm | Arm Label: Health Communication and Obesity Prevention; Type: EXPERIMENTAL; Interventions: Behavioral: Health Communication and Obesity Prevention | Intervention Type: BEHAVIORAL; Name: Health Communication and Obesity Prevention; Assigned to Arm(s): Health Communication and Obesity Prevention | Intervention Type: BEHAVIORAL; Name: Injury Prevention Arm; Assigned to Arm(s): Active Control Arm
D: Arm Label: Comparison Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Parenting Program; Type: EXPERIMENTAL; Interventions: Behavioral: Parenting Program | Intervention Type: BEHAVIORAL; Name: Parenting Program; Assigned to Arm(s): Parenting Program

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Addressing Health Literacy and Numeracy to Prevent Childhood Obesity
Brief Summary: In 2003, Surgeon General Richard Carmona suggested that low health literacy is "one of the largest contributors to our nation's epidemic of overweight and obesity." Over 26% of preschool children are now overweight or obese, and children who are overweight by age 24 months are five times as likely as non-overweight children to become overweight adolescents. The aim of the study is to assess the efficacy of a low-literacy/numeracy-oriented intervention aimed at teaching pediatric resident physicians to promote healthy family lifestyles and prevent overweight among young children (age 0-2) and their families in under-resourced communities.


Options:
A: Arm Label: Active Control Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Injury Prevention Arm | Arm Label: Health Communication and Obesity Prevention; Type: EXPERIMENTAL; Interventions: Behavioral: Health Communication and Obesity Prevention | Intervention Type: BEHAVIORAL; Name: Health Communication and Obesity Prevention; Assigned to Arm(s): Health Communication and Obesity Prevention | Intervention Type: BEHAVIORAL; Name: Injury Prevention Arm; Assigned to Arm(s): Active Control Arm
B: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Start | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Healthy Start; Assigned to Arm(s): Intervention arm
C: Arm Label: motivational counseling; Type: EXPERIMENTAL; Interventions: Behavioral: motivational counseling | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: motivational counseling; Assigned to Arm(s): motivational counseling
D: Arm Label: National Vaccine Program Plus Radio; Type: EXPERIMENTAL; Interventions: Behavioral: Appropriate complementary feeding messages | Arm Label: Comparison (no intervention); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Appropriate complementary feeding messages; Assigned to Arm(s): National Vaccine Program Plus Radio

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Addressing Health Literacy and Numeracy to Prevent Childhood Obesity
Brief Summary: In 2003, Surgeon General Richard Carmona suggested that low health literacy is "one of the largest contributors to our nation's epidemic of overweight and obesity." Over 26% of preschool children are now overweight or obese, and children who are overweight by age 24 months are five times as likely as non-overweight children to become overweight adolescents. The aim of the study is to assess the efficacy of a low-literacy/numeracy-oriented intervention aimed at teaching pediatric resident physicians to promote healthy family lifestyles and prevent overweight among young children (age 0-2) and their families in under-resourced communities.


Options:
A: Arm Label: I, Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Advice | Arm Label: II, Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary Advice; Assigned to Arm(s): I, Intervention
B: Intervention Type: BEHAVIORAL; Name: attitude change; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: adiposity prevention program; Assigned to Arm(s): N/A
C: Arm Label: Active Control Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Injury Prevention Arm | Arm Label: Health Communication and Obesity Prevention; Type: EXPERIMENTAL; Interventions: Behavioral: Health Communication and Obesity Prevention | Intervention Type: BEHAVIORAL; Name: Health Communication and Obesity Prevention; Assigned to Arm(s): Health Communication and Obesity Prevention | Intervention Type: BEHAVIORAL; Name: Injury Prevention Arm; Assigned to Arm(s): Active Control Arm
D: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Behavioral: Education, Behavioral: Problem Solving, Behavioral: Social Learning, Behavioral: Behavior Modification | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Group A, Group B | Intervention Type: BEHAVIORAL; Name: Problem Solving; Assigned to Arm(s): Group A | Intervention Type: BEHAVIORAL; Name: Social Learning; Assigned to Arm(s): Group A | Intervention Type: BEHAVIORAL; Name: Behavior Modification; Assigned to Arm(s): Group A

Answer: C